LATEST

HOW IT DEVELOPED

1. Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness bbc.co.uk  ·  10.11 19:43
2. GLP-1 drugs may increase risk of vision loss from rare condition, FDA warns arstechnica.com  ·  10.11 15:43
3. Pharma firms’ focus on weight-loss drugs could put insulin supply at risk, experts warn theguardian.com  ·  10.11 14:00
4. FDA orders blindness risk warning on weight loss drugs news.sky.com  ·  10.11 01:24
5. Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss marketwatch.com  ·  09.11 18:52

More in this section

Other stories